Fuleihan R, Ramesh N, Horner A, Ahern D, Belshaw P J, Alberg D G, Stamenkovic I, Harmon W, Geha R S
Division of Immunology, Children's Hospital, Boston, Massachusetts.
J Clin Invest. 1994 Mar;93(3):1315-20. doi: 10.1172/JCI117089.
The ligand for CD40 is expressed on activated T lymphocytes and delivers contact-dependent activation signals to B lymphocytes. The mechanisms regulating CD40 ligand gene expression are largely unknown. Optimal expression of CD40 ligand required activation of protein kinase C and a rise in intracellular calcium concentration. CD40 ligand expression was inhibited by pretreatment of T cells with cyclosporin A. Cyclosporin A analogues inhibited CD40 ligand expression with a potency mirroring the ability of each compound to inhibit calcineurin activity, indicating that calcineurin plays a key role in CD40 ligand gene expression. Cyclosporin A inhibited IL-4-driven CD40 ligand-dependent IgE isotype switching in PBMC but did not inhibit IgE synthesis induced by CD40 mAb plus IL-4. PBMC derived from transplant patients receiving cyclosporin A failed to express CD40 ligand upon stimulation. These results suggest that patients receiving cyclosporin A may be deficient in CD40 ligand-dependent T cell help.
CD40的配体在活化的T淋巴细胞上表达,并向B淋巴细胞传递接触依赖性激活信号。调节CD40配体基因表达的机制在很大程度上尚不清楚。CD40配体的最佳表达需要蛋白激酶C的激活和细胞内钙浓度的升高。用环孢素A预处理T细胞可抑制CD40配体的表达。环孢素A类似物抑制CD40配体表达的效力反映了每种化合物抑制钙调神经磷酸酶活性的能力,表明钙调神经磷酸酶在CD40配体基因表达中起关键作用。环孢素A抑制PBMC中IL-4驱动的CD40配体依赖性IgE同种型转换,但不抑制CD40单克隆抗体加IL-4诱导的IgE合成。接受环孢素A治疗的移植患者来源的PBMC在受到刺激时未能表达CD40配体。这些结果表明,接受环孢素A治疗的患者可能缺乏CD40配体依赖性T细胞辅助。